Evidence map›Paper›PMID 36097155›Full record

ArticleEuropean journal of human genetics : EJHG2023

Societal implications of expanded universal carrier screening: a scoping review.

Lieke M van den Heuvel, Nina van den Berg, A Cecile J W Janssens, Erwin Birnie, Lidewij Henneman, Wybo J Dondorp, Mirjam Plantinga, Irene M van Langen

Abstract readScoping Review
In one paragraph

Article in European journal of human genetics : EJHG, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Class II Transactivator Gene (The application of clinical genetics · 2024
    Article
  14. New year, new genes.European journal of human genetics : EJHG · 2023
    Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Lieke M van den HeuvelDepartment of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Nina van den BergDepartment of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
A Cecile J W JanssensDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Erwin BirnieDepartment of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Lidewij HennemanDepartment of Human Genetics and Amsterdam Reproduction and Development research institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0003-3531-0597
Wybo J DondorpDepartment of Health, Ethics & Society, Research Schools CAPHRI and GROW, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0003-4052-7192
Mirjam PlantingaDepartment of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Irene M van LangenDepartment of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. i.m.van.langen@umcg.nl.ORCID 0000-0002-0960-7154

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carrier screening aims to identify couples at risk of conceiving children with a recessive condition. Until recently, carrier screening was primarily offered ancestry-based. Technological advances now facilitate expanded universal carrier screening (EUCS). This scoping review aimed to map EUCS's potential societal implications based on both theoretical studies and empirical evidence. To this aim, we performed a CoCites search to find relevant articles, including articles describing carrier screening for at-risk populations, based on five selected query articles. Forty articles were included. Three main potential societal implications were identified: (1) unwanted medicalization, (2) stigmatization and discrimination of carriers and people affected with the conditions screened and (3) challenges in achieving equitable access. Within these themes, potential positive implications are reduction of ethnic stigmatization in ancestry-based offers and increased equity. Potential negative implications are reinforcement of disability-based stigmatization, less possibility for developing expertise in healthcare and societal pressure to partake in screening. Empirical evidence on all these implications is however scarce. In conclusion, both positive and negative potential societal implications of implementing EUCS, primarily theoretical, were identified, even in at-risk groups where evidence is mostly lacking. Empirical research in EUCS pilots is needed to identify which societal implications are likely to occur and therefore should be overcome when implementing EUCS.

Indexed as

Genetic Carrier ScreeningChildHumansRisk Factors

Identifiers

PMID36097155
PMCPMC9822904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.